Erythrocyte as a therapeutic target by Saldanha, Carlota & Herdade, Ana Silva
Mini Review
Volume 2 Issue 3 - August  2017
Nov Appro Drug Des DevCopyright © All rights are reserved by  Carlota Saldanha
Erythrocyte as a Therapeutic Target
Carlota Saldanha* and Ana Silva Herdade
Institute of Biochemistry, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon. Portugal
Submission: July 31, 2017; Published: August 09, 2017
*Corresponding author: Carlota Saldanha, Institute of Biochemistry, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon. Portugal, Email: 
Mini ReviewMore than two centuries ago was discovered in blood the presence of erythrocytes and its vital function as the unique oxygen carrier binding to hemoglobin which molecular and structural characterizations where later described [1-5]. Erythrocytes with different shapes are observed in association with some hemoglobinophaties for example sickle cell disease, 
or in those resulting from inserted compounds into specific membrane domains [6,7].Erythrocyte metabolism provides metabolites able 
to regulate the oxygen affinity for hemoglobin such as 2,3-bisposphoglycerate and others to participate as coenzymes in antioxidant pathways [8]. Several therapeutically drugs cause hemolysis in humans with glucose-6-phospate dehydrogenase null gene [9]. A reducing environment inside of erythrocytes ensures the active form of hemoglobin with its ferric ion and the normal interaction between biomolecules of the membrane bilayer and the proteins of cytoskeleton [10]. However, when erythrocytes show higher pro-oxidant activity contribute to abnormal biorheological functions associated with 
inflammatory vascular diseases [11,12]. They can be a trigger or a consequence of micro or macro circulation dysfunction. Acquired ability of erythrocytes to combine with partners of hemostatics components generate red thrombus and help the 
rolling and adhesion of white blood cells to vascular endothelial wall [13,14].Erythrocytes are enucleated blood components, but are more than sacks of hemoglobin during the semi life of 120 days comporting different signaling pathways in which is 
included the final stage of apoptosis (eryptosis) that has been 
evidenced [15,16]. The appearance in plasma of exovesicules 
enriched with the acetylcholinesterase (AChE) originated from erythrocyte membrane, the phosphatydilserine exposition in the outer membrane of erythrocyte in addition to kinetic changes of the AChE evaluated in older erythrocytes are biomarkers of 
red blood cells senescence (RBCs) [17,18]. Previously AChE in erythrocytes was evidenced as a biomarker of its membrane integrity [19].Depending on the degree of endothelium integrity 
the circulating acetylcholine [ACh) induce vasodilation or 
vasoconstriction according the amount of nitric oxide (NO) 
synthesised and released [20,21]. The NO released from endothelial cells and platelets is scavenged by erythrocyte and blood cell free haemoglobin [22].Erythrocyte membrane AChE is involved in the nitric oxide 
(NO) signal pathway as evidenced, for the first time, using blood 
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Abstract
Erythrocytes are powerful components of blood flow designed to scavenger or deliver nitic oxide (NO) and oxygen to all cells in the 
body and transport carbon dioxide from them to the lungs. Blood components started to be quantified and erythrocyte blood shapes used as 
diagnostic and prognostic tools in clinical practice. Erythrocytes have hemorheological, hemostatic and pro or anti-inflammatory properties enlarging their physiological implications in health and disease. As blood component the erythrocytes establish interaction with others white 
blood cells, platelets, plasma lipoproteins and vascular endothelial cells. The aim of this mini review is highlight the signaling pathway of nitric 
oxide in which some steps explain the efficacy of some therapeutic drugs already used and could point new targets for further application in 
inflammatory vascular diseases
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samples from blood donors in several in vitro studies in the 
begin of this century [23,24]. No metabolism provides several 
NO derivative molecules such as nitrite, nitrate, peroxynitrite 
and S-nitro glutathione (GSNO) behavior the last one as NO 
reservoir such as S -nitrosohemoglobin [23,24]. The signal transduction pathway mediated by the enzymatic complex 
form AChE-ACh is coupled to Gαiproein, adenylil cyclase (AC), 
band3 protein, protein kinase C (PKC) and phosphodiesterase-3 
(PDE-3) [24]. The ACh concentration used is below its substrate 
optimum concentration [25]. The substrate concentration correspondent to the velocity maximum obtained in the bell 
shape kinetic curve [25,26]. Higher NO efflux occurs under 
the influence of AChE-Ach complex, in simultaneous with the band3 protein phosphorylation [23,24]. Compounds that inhibit the protein tyrosine kinase or protein tyrosine phosphatase induce inhibition or activation on AChE enzyme activity [24]. Used two types of AChE inhibitors, velnacrine maleate and timolol generate inactive or less active enzyme AChE-inhibitor 
complexes that impaired NO efflux from erythrocytes in relation to the active form ACh- AChE [23,27].In patients with open angle glaucoma, over expression of 
eNOS and nNOS, decreased levels of cGMP (intermediate in NO 
signaling) and of nitrite (NO metabolite)in aqueous humour and increased erythrocyte AChE activity were described [28-30]. When blood samples from glaucoma patients is incubated in-
vitro in presence of timolol, no changes in the NO efflux neither 
in the GSNO content of erythrocytes were evidenced besides both molecules are in higher concentrations than the normal 
values obtained in health humans [31]. This study showed that no reinforcement will occur in the amount of nitrogen reactive stress characteristic of glaucoma patients, by timolol application [31].Insulin resistance can be eliminated in some patients with sepsis by continuous intravenous infusion of insulin in the 
form of glucose-insulin-potassium (GIP) regimen that improves survival [32,33]. When blood samples from patients with septic shock where incubated in-vitro with insulin increased the 
amount of GSNO and the concentration of NO inside erythrocytes was maintained between the normal values [34]. A positive 
association was observed between NO efflux from erythrocyte and perfused vessel density at sub-lingual microcirculation [34]. 
So the GPI regimen protected from nitrogen reactive stress [34].
When fibrinogenemia is mimicked in- vitro NO efflux from erythrocyte increases, in dependence of band3 protein phosphorylation, returning to normal levels when in presence of either ACh or timolol showing dependency of the AChE enzyme conformational states and of the lower levels of cyclic 
adenosine Monophosphate (cAMP)concentrations [27,35-37]. 
When the inhibitor of the erythrocyte Casein Kinase 2, (a cytosol 
protein that phosphorylated band 3 protein), is present in the 
erythrocytes suspensions at high fibrinogen concentration the 
NO efflux level is maintained between normal values confirmed 
its dependence of band 3 de phosphorylating for be rescued by 
RBCs [38]. Is very interesting that the forskolin, activator of AC enzyme 
normalize the levels of NO efflux from erythrocytes in in-vitro 
model of hyper fibrinogenemia, is nowadays used to alleviate patients with glaucoma [39]. As mentioned above glaucoma patient’s present increase 
nitrogen reactive species in aqueous humor and NO efflux from their erythrocytes are higher than healthy humans [28,31]. So, one explanation for the forskolin therapeutic success in 
glaucoma patient’s could result from NO efflux from their 
erythrocyte be dependent of lower cAMP levels. This make sense 
because glaucoma is an inflammatory disease where patients 
have increased levels of fibrinogen which is known its binding to 
erythrocyte membrane CD47 that by association with Gαiprotein and AC inhibition decreased cAMP concentrations. [37,40,41]. Besides, this is a clue need to be explored.
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